Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Change in Accured Expenses (2016 - 2025)

Xtant Medical Holdings has reported Change in Accured Expenses over the past 16 years, most recently at $958000.0 for Q3 2025.

  • Quarterly Change in Accured Expenses rose 333.48% to $958000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $2.6 million through Sep 2025, up 724.76% year-over-year, with the annual reading at -$2.9 million for FY2024, 176.95% down from the prior year.
  • Change in Accured Expenses was $958000.0 for Q3 2025 at Xtant Medical Holdings, up from $23000.0 in the prior quarter.
  • Over five years, Change in Accured Expenses peaked at $2.7 million in Q1 2025 and troughed at -$1.6 million in Q3 2021.
  • The 5-year median for Change in Accured Expenses is $221000.0 (2024), against an average of $243526.3.
  • Year-over-year, Change in Accured Expenses surged 10636.36% in 2021 and then crashed 788.78% in 2024.
  • A 5-year view of Change in Accured Expenses shows it stood at $270000.0 in 2021, then skyrocketed by 75.93% to $475000.0 in 2022, then surged by 198.74% to $1.4 million in 2023, then plummeted by 175.55% to -$1.1 million in 2024, then skyrocketed by 189.37% to $958000.0 in 2025.
  • Per Business Quant, the three most recent readings for XTNT's Change in Accured Expenses are $958000.0 (Q3 2025), $23000.0 (Q2 2025), and $2.7 million (Q1 2025).